Citations (18)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Yuan Ma, Yan Zheng, Yanli Ji, Xiuli Wang & Baoxian Ye. (2021) Raloxifene, Identified As a Novel LSD1 Inhibitor, Suppresses the Migration of Renal Cell Carcinoma. Future Medicinal Chemistry 13:6, pages 533-542.
Read now
Read now
Articles from other publishers (17)
Hui‐Min Liu, Ying Zhou, He‐Xiang Chen, Jiang‐Wan Wu, Shi‐Kun Ji, Liang Shen, Shao‐Peng Wang, Hong‐Min Liu, Ying Liu, Xing‐Jie Dai & Yi‐Chao Zheng. (2023) LSD1 in drug discovery: From biological function to clinical application. Medicinal Research Reviews 44:2, pages 833-866.
Crossref
Crossref
Abeer A. Alsofyani & Yazan Samih Said. 2023. Molecular Targets and Cancer Therapeutics (Part 1). Molecular Targets and Cancer Therapeutics (Part 1)
320
366
.
Lihong Shan, Zhaoxiang Li, Huabin Chen, Meng Ge, Yingying Sun, Ying Sun, Yaru Li, Hongyu Li, Ling Fu & Hongmin Liu. (2023) 6-Heterocyclic carboxylic ester derivatives of gliotoxin lead to LSD1 inhibitors in gastric cancer cells. Bioorganic Chemistry 131, pages 106150.
Crossref
Crossref
Adrian Kwan Ho Loe, Lexin Zhu & Tae-Hee Kim. (2023) Chromatin and noncoding RNA-mediated mechanisms of gastric tumorigenesis. Experimental & Molecular Medicine 55:1, pages 22-31.
Crossref
Crossref
Hao Wang & Fang Liu. (2023) LSD1 Silencing Inhibits the Proliferation, Migration, Invasion, and Epithelial-To-Mesenchymal Transition of Hypopharyngeal Cancer Cells by Inducing Autophagy and Pyroptosis. Chinese Journal of Physiology 66:3, pages 162-170.
Crossref
Crossref
Jemma Arakelyan, Daniil A. Rusanov, Meng Rui Chang, Aleksandra V. Asaturova, Galina S. Kireeva, Mana Alshehri, Wee Han Ang & Maria V. Babak. (2023) Targeting emerging cancer hallmarks by transition metal complexes: Epigenetic reprogramming and epitherapies. Part II. Coordination Chemistry Reviews 475, pages 214899.
Crossref
Crossref
Xu-yang Zhang, Pan Hao, Jun-wei Wang, Wen Zhao, Hong-min Liu & Peng-xing He. (2022) Inhibition of lysine-specific demethylase 1 enhances the sensitivity of the chemotherapeutic drug doxorubicin in gastric cancer cell. Molecular Biology Reports 50:1, pages 507-516.
Crossref
Crossref
Simona-Adriana Manea, Mihaela-Loredana Vlad, Alexandra-Gela Lazar, Horia Muresian, Maya Simionescu & Adrian Manea. (2022) Pharmacological Inhibition of Lysine-Specific Demethylase 1A Reduces Atherosclerotic Lesion Formation in Apolipoprotein E-Deficient Mice by a Mechanism Involving Decreased Oxidative Stress and Inflammation; Potential Implications in Human Atherosclerosis. Antioxidants 11:12, pages 2382.
Crossref
Crossref
Chao Yang, Dan Li, Shaohong Zang, Lei Zhang, Zhangfeng Zhong & Yingtang Zhou. (2022) Mechanisms of carcinogenic activity triggered by lysine-specific demethylase 1A. Frontiers in Pharmacology 13.
Crossref
Crossref
Julien Jarroux, Dominika Foretek, Claire Bertrand, Marc Gabriel, Ugo Szachnowski, Zohra Saci, Shuling Guo, Arturo Londoño‐Vallejo, Marina Pinskaya & Antonin Morillon. (2021) HOTAIR lncRNA promotes epithelial–mesenchymal transition by redistributing LSD1 at regulatory chromatin regions. EMBO reports 22:7.
Crossref
Crossref
Peizhi Ma, Gang Jia & Zhiyu Song. (2021) Monobenzone, a Novel and Potent KDM1A Inhibitor, Suppresses Migration of Gastric Cancer Cells. Frontiers in Pharmacology 12.
Crossref
Crossref
Lanxin Jiang, Xiaomin Gong, Wangdi Liao, Nonghua Lv & Runwei Yan. (2021) Molecular targeted treatment and drug delivery system for gastric cancer. Journal of Cancer Research and Clinical Oncology 147:4, pages 973-986.
Crossref
Crossref
Clement Agboyibor, Jianshu Dong, Clement Y. Effah, Emmanuel K. Drokow, Waqar Pervaiz, Dié Li, Lei Kang, Xinli Ma, Jian Li, Zhenzhen Liu & Hong-Min Liu. (2021) Systematic Review and Meta-Analysis of Lysine-Specific Demethylase 1 Expression as a Prognostic Biomarker of Cancer Survival and Disease Progression. Cancer Control 28, pages 107327482110515.
Crossref
Crossref
Yutian Pan, Yuan Fang, Mengyan Xie, Yu Liu, Tao Yu, Xi Wu, Tongpeng Xu, Pei Ma & Yongqian Shu. (2020) LINC00675 Suppresses Cell Proliferation and Migration via Downregulating the H3K4me2 Level at the SPRY4 Promoter in Gastric Cancer. Molecular Therapy - Nucleic Acids 22, pages 766-778.
Crossref
Crossref
Miaoyun Long, Yue Zhu, Zuhe Chen, Shaojian Lin, Xinzhi Peng, Dingyuan Luo, Honghao Li & Langping Tan. (2020) Lysine-Specific Demethylase 1 Affects the Progression of Papillary Thyroid Carcinoma via HIF1α and microRNA-146a. The Journal of Clinical Endocrinology & Metabolism 105:7, pages 2237-2251.
Crossref
Crossref
Lei Wang, Lingzhao Li, Quanxiang Han, Xiaofang Wang, Di Zhao & Junqi Liu. (2020) Identification and biological evaluation of natural product Biochanin A. Bioorganic Chemistry 97, pages 103674.
Crossref
Crossref
lihong shan, Zhaoxiang Li, Huabin Chen, Meng Ge, Yingying Sun, Ying Sun, Yaru Li, Hongyu Li, Ling Fu & Hong-Min Liu. (2022) 6-Heterocyclic Carboxylic Ester Derivatives of Gliotoxin Lead to LSD1 Inhibitors in Gastric Cancer Cells. SSRN Electronic Journal.
Crossref
Crossref